isomethyleugenol has been researched along with camptothecin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Eng, WK; Hertzberg, RP; Hofmann, GA; Johnson, RK; Mattern, MR; McCabe, FL; Rieman, DJ; Tan, KB; Woessner, RD | 1 |
| Abbruzzese, JL; Anzai, H; Frost, P | 1 |
| Desrosiers, R; Tanguay, RM | 1 |
| Eng, WK; Johnson, RK; Mattern, MR; McCabe, FL; Tan, KB | 1 |
| Bloom, SE; Muscarella, DE; Vogt, VM | 1 |
| Dysard, R; Kessel, D | 1 |
| Che, X; Ji, H; Miao, Z; Shao, L; Sheng, C; Yao, J; You, L; Zhang, J; Zhang, M; Zhang, W | 1 |
| Beese-Sims, SE; Colaiácovo, MP; Nottke, AC; Pantalena, LF; Reinke, V; Shi, Y | 1 |
| Ding, Y; Guan, W; Liu, B; Qian, X; Shen, J; Wang, H; Wei, J; Xie, L; Yang, Y; Yu, L; Yue, G; Zou, Z | 1 |
| Ahlf, DR; Catherman, AD; Durbin, KR; Early, BP; Fellers, RT; Kelleher, NL; Thomas, PM; Tran, JC | 1 |
| Fan, WF; Liu, BR; Meng, LJ; Shen, J; Wang, J; Wang, L | 1 |
| Chen, HL; Cheng, PL; Goto, M; Hsieh, KY; Lee, KH; Liu, YQ; Morris-Natschke, SL; Yang, GZ; Yang, QR; Zhang, N; Zhang, XS; Zhu, GX | 1 |
| Bähr, O; Belka, C; Braun, C; Gerlach, R; Glas, M; Goldbrunner, R; Hänel, M; Hattingen, E; Hau, P; Herrlinger, U; Junold, N; Kebir, S; Kortmann, RD; Krex, D; Mack, F; Niessen, M; Proescholdt, M; Rohde, V; Sabel, M; Schäfer, N; Schaub, C; Schlegel, U; Schmidt-Graf, F; Steinbach, JP; Stuplich, M; Tzaridis, T; Vatter, H; Weyerbrock, A | 1 |
| Büttner-Herold, M; Distel, L; Fietkau, R; Gottwald, D; Hecht, M; Hohmann, N; Putz, F | 1 |
1 trial(s) available for isomethyleugenol and camptothecin
| Article | Year |
|---|---|
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cell Growth Processes; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Methylation; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy; Temozolomide; Tumor Suppressor Proteins | 2018 |
13 other study(ies) available for isomethyleugenol and camptothecin
| Article | Year |
|---|---|
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.
Topics: Animals; Camptothecin; Cell Nucleus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression; Genes; In Vitro Techniques; Macrophages; Methylation; Mice; RNA, Messenger; Tumor Cells, Cultured | 1992 |
Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Colorectal Neoplasms; Decitabine; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Lethal Dose 50; Methylation; Mice; Mice, Inbred BALB C; Topotecan; Tumor Cells, Cultured | 1992 |
Transcriptional inhibitors affecting topoisomerase II induce changes in histone methylation patterns similar to those induced by heat shock.
Topics: Animals; Camptothecin; Cells, Cultured; Dactinomycin; Drosophila melanogaster; Ethidium; Histones; Hot Temperature; In Vitro Techniques; Methylation; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Uridine | 1989 |
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.
Topics: Alleles; Amsacrine; Animals; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression Regulation; Gene Rearrangement; Leukemia P388; Leukemia, Experimental; Methylation; Methyltransferases; Mice; RNA, Messenger; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic | 1989 |
Characterization of ribosomal RNA synthesis in a gene dosage mutant: the relationship of topoisomerase I and chromatin structure to transcriptional activity.
Topics: Aneuploidy; Animals; Camptothecin; Cell Nucleus; Chickens; Chromatin; Dactinomycin; Deoxyribonuclease I; DNA Topoisomerases, Type I; DNA, Ribosomal; Endonucleases; Gene Expression Regulation; Genes; Methylation; RNA Processing, Post-Transcriptional; RNA, Ribosomal; Single-Strand Specific DNA and RNA Endonucleases; Transcription, Genetic | 1987 |
Effects of camptothecin on RNA synthesis in L-1210 cells.
Topics: Animals; Camptothecin; Carbon Isotopes; Centrifugation, Density Gradient; Clone Cells; Leukemia L1210; Methylation; Mice; Nucleotides; Phosphorus Isotopes; RNA; RNA, Ribosomal; Time Factors; Uridine | 1973 |
New homocamptothecins: synthesis, antitumor activity, and molecular modeling.
Topics: Antineoplastic Agents; Binding Sites; Camptothecin; Cell Line, Tumor; Cell Survival; DNA Topoisomerases, Type I; Humans; Imaging, Three-Dimensional; Imines; Methylation; Models, Molecular; Molecular Structure; Protein Binding; Pyridines; Quantitative Structure-Activity Relationship; Solubility; Water | 2008 |
SPR-5 is a histone H3K4 demethylase with a role in meiotic double-strand break repair.
Topics: Animals; Animals, Genetically Modified; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Camptothecin; DNA Breaks, Double-Stranded; DNA Repair; Gene Expression Profiling; Germ Cells; Green Fluorescent Proteins; Histones; Lysine; Meiosis; Methylation; Microscopy, Fluorescence; Mutation; Oligonucleotide Array Sequence Analysis; Oxidoreductases, N-Demethylating; Rad51 Recombinase; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2011 |
A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biomarkers, Tumor; Camptothecin; Drug Screening Assays, Antitumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Male; Methylation; Mice; Middle Aged; Models, Genetic; Neoplasm Proteins; Reproducibility of Results; Stomach Neoplasms; Sulfatases; Sulfotransferases; Xenograft Model Antitumor Assays | 2013 |
Large-scale top-down proteomics of the human proteome: membrane proteins, mitochondria, and senescence.
Topics: Camptothecin; Cell Fractionation; Cell Line, Transformed; Cellular Senescence; Chromatography, Liquid; Epithelial Cells; Gene Expression Regulation; High-Throughput Screening Assays; Humans; Membrane Proteins; Methylation; Mitochondria; Mitochondrial Proteins; Molecular Sequence Annotation; Multienzyme Complexes; Phosphorylation; Protein Processing, Post-Translational; Proteomics; Signal Transduction; Tandem Mass Spectrometry | 2013 |
[Correlation between the methylation of SULF2 and WRN promoter and chemosensitivity to irinotecan in gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; DNA Methylation; Exodeoxyribonucleases; Humans; Irinotecan; Methylation; Promoter Regions, Genetic; RecQ Helicases; Stomach Neoplasms; Sulfatases; Sulfotransferases; Werner Syndrome Helicase | 2013 |
Design, synthesis and potent cytotoxic activity of novel 7-(N-[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; Humans; Methylation; Neoplasms; Piperazine; Piperazines; Sulfones | 2017 |
Role of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cadherins; Camptothecin; Cell Line, Tumor; Cell Survival; Cell-in-Cell Formation; Cellular Senescence; Cohort Studies; Female; Fibroblasts; Heat-Shock Response; Histones; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Methylation; Middle Aged; Necrosis; Phagocytosis; Prognosis; Rectal Neoplasms | 2020 |